NEW YORK (TheStreet) -- On his Stop Trading! segment on CNBC Friday, Jim Cramer addressed Bristol-Myers Squibb (BMY) - Get Bristol-Myers Squibb Company Report in light of recent stock upgrades by several firms.
"Their oncological programs are amazing," Cramer said. He also complimented the company's yields.
Still, as much as he likes the stock, he noted that some forecasts call for an earnings drop off at the company, as certain Bristol drugs come off of patent. That said, he cautioned that the stock may not look as safe as many believe.
executives recently touted the bank's "brilliant" mid-term outlook. Cramer agreed that Santander has "great" American assets and Brazil operations, and calls it "the canary in the coal mine."
However, Cramer said he wouldn't go long or short shares of this Spanish bank for now. Many in the investment community have expressed doubt about those bullish projections by bank executives, as the European debt crisis lingers on. "Their outlook was so upbeat," Cramer said. Yet many "don't believe a word they say."
Tech names that Cramer mentioned Friday include
, which he said has really "under-promised and over-delivered" and
, which has been one of the top five percentage gainers on the S&P 500 Index Friday.
"This kind of action at National Semiconductor makes me feel more optimistic about tech," Cramer said.
came closer to a decision about whether to cut its dividends, Cramer said, "I think this stock represents great value, but you're dealing with government." He believes the White House will continue to go after BP, given President Obama's slipping approval ratings. "When you've got a president and an angry Congress, no one's safe," he said.
Cramer's Stop Trading!: Apple, Citi, Google
-- Reported by Andrea Tse in New York
Follow TheStreet.com on
and become a fan on
Copyright 2010 TheStreet.com Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.